Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-12-27

Clinical Trial Update: Study to Assess the Safety of DERMASEAL for Diabetic Foot Ulcers [Phase 1]

View source ↗

Summary

Clinical trial update on the Phase 1 safety study of DERMASEAL for diabetic foot ulcers. The study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DERMASEAL

Snippet

Sponsor: Vitruvian Medical Devices, Inc. | Conditions: Foot Ulcer, Diabetic | Phase 1 | Status: ACTIVE_NOT_RECRUITING